Julius Clinical is proud to announce our continued sponsorship of Bio-Neuroscience 2025, the premier summit for CEOs, investors, and industry decision-makers in CNS neuroscience drug development.

Taking place in Amsterdam from 25-27 February 2025, this exclusive, high-level event is limited to 200 carefully selected participants, including prominent CNS-focused VC funds, industry leaders, and CEOs of some of the most promising companies in neuroscience drug development.

As part of our commitment to advancing neuroscience research, our team members Nurit Novak, Helen Blackshaw, and Erik van Zandbergen will be present to connect with industry leaders, share insights, and explore collaborative opportunities.

In celebration of our sponsorship, we are offering an exclusive discount to interested partners. To learn more about this opportunity and how Julius Clinical can support your clinical trial needs with our scientific expertise and operational excellence, please contact us directly.

 

For more information about the conference, please visit the Bio-Neuroscience website.